# Guidance on the planning and reporting of experimental design and analysis

“Guidance on the planning and reporting of experimental design and analysis” (2025), by Michael J. Curtis et al. Arts and Humanities research paper. Original abstract below, unchanged. No free PDF was found.

- Authors: Michael J. Curtis, S P H Alexander, Miriam Margherita Cortese-Krott, David A. Kendall, Kirill A. Martemyanov, Claudio Mauro, Reynold A. Panettieri, Andreas Papapetropoulos, Hemal H. Patel, Evan E. Santo et al.
- Published: January 26, 2025
- Field: Arts and Humanities
- DOI: https://doi.org/10.1111/bph.17441
- Source: https://doi.org/10.1111/bph.17441

## Abstract

The aim of this guidance document is to help authors plan experiments, conduct analyses and present the results of work intended for publication in the British Journal of Pharmacology (BJP).The guidance is structured to minimize the risk of generating and publishing false findings.Below, we explain the key elements of experimental planning (blinding, randomization and adequate group sizes) and how to avoid generating incorrect findings (false positives in particular).We explain how to capture the relevant design and analysis information in your manuscript so it can be examined quickly, efficiently and fairly in peer review.In accordance with previous modifications to our requirements at BJP, we have eliminated a great deal of the items set forth in the most recent guidance document (Curtis et al., 2022) that were found to be too granular or subject-specific.We also hope to dispel some myths about what BJP will consider, in a clear and helpful manner, and encourage more authors to submit their work confidently to the journal according to the vision of the editorial board (Papapetropoulos et al., 2023).

Canonical page: https://nerdi.pages.dev/paper/W4406849664
Read three real papers a day in Nerdi (iPhone): https://apps.apple.com/app/apple-store/id6813826387?pt=128757794&ct=web-paper&mt=8